Department of Ultrasound, First People's Hospital of Foshan, Foshan, China.
Zhuhai Campus, Zunyi Medical University, Zunyi, China.
Horm Metab Res. 2023 Sep;55(9):585-591. doi: 10.1055/a-2142-4811. Epub 2023 Jul 27.
To study risk factors for central lymph node metastasis (CLNM) in papillary thyroid cancer (PTC) using the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS). We retrospectively analysed patients who underwent PTC surgery and central lymph node dissection at First People's Hospital of Foshan City. The clinical and ultrasonic data of the patients from 1150 cases were analysed by multivariate regression to evaluate the correlation between grayscale ultrasound (US) features, C-TIRADS score, and the classification of thyroid nodules and CLNM of PTCs. The C-TIRADS score was 3.0±1.0 in the CLNM group, which was higher than that in the non-CLNM group (p<0.001). Sex (male) (OR=1.586, 95% CI 1.232-2.042, p<0.001), age (≤45 years) (OR=1.508, 95% CI 1.184-1.919, p=0.001), location of nodes (lower pole) (OR=2.193, 95% CI 1.519-3.166, p<0.001), number (multifocal) (OR=2.204, 95% CI 1.227-2.378, p<0.001), microcalcification (OR=1.610, 95% CI 2.225-4.434, p=0.002), extrathyroidal extension (OR=2.204, 95% CI 1.941-3.843, p<0.001), maximum diameter of nodule (≥20 mm) (OR=3.211, 95% CI 2.337-4.411, p<0.001), and C-TIRADS score (OR=1.356, 95% CI 1.204-1.527, p<0.001) were PTC in independent risk factors for CLNM. The C-TIRADS score of PTC combined with the location, number, size, and ultrasound features of the lesion and the patient's sex and age are important in predicting whether they present with CLNM and provide a reference basis for the clinical formulation of a reasonable surgical treatment plan.
利用中国甲状腺影像报告和数据系统(C-TIRADS)研究甲状腺乳头状癌(PTC)中央淋巴结转移(CLNM)的危险因素。我们回顾性分析了在佛山市第一人民医院接受 PTC 手术和中央淋巴结清扫术的患者。通过多元回归分析 1150 例患者的临床和超声数据,评估灰阶超声(US)特征、C-TIRADS 评分、甲状腺结节分类与 PTC 中央淋巴结转移的相关性。CLNM 组的 C-TIRADS 评分为 3.0±1.0,高于非 CLNM 组(p<0.001)。性别(男性)(OR=1.586,95%CI 1.232-2.042,p<0.001)、年龄(≤45 岁)(OR=1.508,95%CI 1.184-1.919,p=0.001)、淋巴结位置(下极)(OR=2.193,95%CI 1.519-3.166,p<0.001)、数量(多灶性)(OR=2.204,95%CI 1.227-2.378,p<0.001)、微钙化(OR=1.610,95%CI 2.225-4.434,p=0.002)、甲状腺外侵犯(OR=2.204,95%CI 1.941-3.843,p<0.001)、结节最大直径(≥20mm)(OR=3.211,95%CI 2.337-4.411,p<0.001)和 C-TIRADS 评分(OR=1.356,95%CI 1.204-1.527,p<0.001)是 PTC 发生 CLNM 的独立危险因素。PTC 的 C-TIRADS 评分结合病变的位置、数量、大小和超声特征以及患者的性别和年龄,对预测 CLNM 具有重要意义,并为临床制定合理的手术治疗方案提供参考依据。